B. Fan, Y. Malato, and D. Calvisi, Cholangiocarcinomas can originate from hepatocytes in mice, Journal of Clinical Investigation, vol.122, issue.8, pp.2911-2915, 2012.
DOI : 10.1172/JCI63212DS1

B. Blechacz, M. Komuta, T. Roskams, and G. Gores, Clinical diagnosis and staging of cholangiocarcinoma, Nature Reviews Gastroenterology & Hepatology, vol.31, issue.9, pp.512-522, 2011.
DOI : 10.1038/nrgastro.2011.131

J. Bridgewater and P. Galle, Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma, Journal of Hepatology, vol.60, issue.6, pp.1268-1289, 2014.
DOI : 10.1016/j.jhep.2014.01.021

S. Khan, S. Emadossadaty, N. Ladep, H. Thomas, P. Elliott et al., Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us?, Journal of Hepatology, vol.56, issue.4, pp.848-854, 2012.
DOI : 10.1016/j.jhep.2011.11.015

G. Tyson and H. El-serag, Risk factors for cholangiocarcinoma, Hepatology, vol.27, issue.Suppl 2, pp.173-84, 2011.
DOI : 10.1002/hep.24351

T. Patel, Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States, Hepatology, vol.33, issue.6, pp.1353-1357, 2001.
DOI : 10.1053/jhep.2001.25087

S. Taylor-robinson, M. Toledano, and S. Arora, Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998, Gut, vol.48, issue.6, pp.816-820, 1968.
DOI : 10.1136/gut.48.6.816

D. Alvaro, E. Crocettib, S. Ferretti, and M. Bragazzia, Descriptive epidemiology of cholangiocarcinoma in Italy, Digestive and Liver Disease, vol.42, issue.7, pp.490-495, 2010.
DOI : 10.1016/j.dld.2009.10.009

V. Hahn, S. Ciesek, G. Wegener, and R. Plentz, Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany, Scandinavian Journal of Gastroenterology, vol.45, issue.11, pp.1092-1100, 2011.
DOI : 10.1242/dev.029140

C. Lepage, V. Cottet, M. Chauvenet, and J. Phelip, Trends in the incidence and management of biliary tract cancer: A French population-based study, Journal of Hepatology, vol.54, issue.2, pp.306-310, 2011.
DOI : 10.1016/j.jhep.2010.06.039

P. Jepsen, H. Vilstrup, R. Tarone, S. Friis, and H. Sørensen, Incidence Rates of Intra- and Extrahepatic Cholangiocarcinomas in Denmark From 1978 Through 2002, JNCI Journal of the National Cancer Institute, vol.99, issue.11, pp.895-97, 2007.
DOI : 10.1093/jnci/djk201

S. Rizvi and G. Gores, Molecular Pathogenesis of Cholangiocarcinoma, Digestive Diseases, vol.32, issue.5, pp.564-573, 2014.
DOI : 10.1159/000360502

J. Andersen, B. Spee, B. Blechacz, I. Avital, M. Komuta et al., Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors, Gastroenterology, vol.142, issue.4, pp.1021-1052, 2012.
DOI : 10.1053/j.gastro.2011.12.005

D. Sia, Y. Hoshida, A. Villanueva, S. Roayaie, J. Ferrer et al., Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes, Gastroenterology, vol.144, issue.4, pp.829-869, 2013.
DOI : 10.1053/j.gastro.2013.01.001

A. Tannapfel, M. Benicke, A. Katalinic, D. Uhlmann, F. Köckerling et al., Frequency of p16INK4A alterations and k-ras mutations in intrahepatic cholangiocarcinoma of the liver, Gut, vol.47, issue.5, pp.721-728, 2000.
DOI : 10.1136/gut.47.5.721

O. Dell, M. Huang, J. Whitney-miller, C. Deshpande, V. Rothberg et al., KrasG12D and p53 Mutation Cause Primary Intrahepatic Cholangiocarcinoma, Cancer Research, vol.72, issue.6, pp.1557-67, 2012.
DOI : 10.1158/0008-5472.CAN-11-3596

T. Chen, T. Yeh, and Y. Jan, K-ras Mutation is Strongly Associated with Perineural Invasion and Represents an Independent Prognostic Factor of Intrahepatic Cholangiocarcinoma after Hepatectomy, Annals of Surgical Oncology, vol.359, issue.S3, pp.675-81
DOI : 10.1245/s10434-012-2224-7

J. Park, L. Tadlock, G. Gores, and T. Patel, Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line, Hepatology, vol.272, issue.5, pp.1128-1161, 1999.
DOI : 10.1002/hep.510300522

R. Al-bahrani, Y. Abuetabh, N. Zeitouni, and C. Sergi, Cholangiocarcinoma: risk factors, environmental influences and oncogenesis, Ann Clin Lab Sci, vol.43, issue.2, pp.195-210, 2013.

K. Nakazawa, Y. Dobashi, S. Suzuki, H. Fujii, and A. Ooi, Amplification and overexpression of c-erbB-2,epidermal growth factor receptor, and c-met in biliary tract cancers, The Journal of Pathology, vol.29, issue.3, pp.356-65, 2005.
DOI : 10.1002/path.1779

F. Leone, G. Cavalloni, Y. Pignochino, I. Sarotto, R. Ferraris et al., Somatic Mutations of Epidermal Growth Factor Receptor in Bile Duct and Gallbladder Carcinoma, Clinical Cancer Research, vol.12, issue.6, pp.1680-1685, 2006.
DOI : 10.1158/1078-0432.CCR-05-1692

D. Sia, V. Tovar, A. Moeini, and J. Llovet, Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies, Oncogene, vol.23, issue.41, pp.4861-70, 2013.
DOI : 10.1038/onc.2012.617

S. Zender, I. Nickeleit, T. Wuestefeld, I. Sörensen, D. Dauch et al., A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas, Cancer Cell, vol.23, issue.6, pp.784-95, 2013.
DOI : 10.1016/j.ccr.2013.04.019

N. Ishimura, S. Bronk, and G. Gores, Inducible Nitric Oxide Synthase Up-Regulates Notch-1 in Mouse Cholangiocytes: Implications for Carcinogenesis, Gastroenterology, vol.128, issue.5, pp.1354-68, 2005.
DOI : 10.1053/j.gastro.2005.01.055

Y. Saito, H. Suzuki, M. Matsuura, A. Sato, Y. Kasai et al., MicroRNAs in Hepatobiliary and Pancreatic Cancers, Frontiers in Genetics, vol.2, pp.2-66, 2011.
DOI : 10.3389/fgene.2011.00066

S. Khan, H. Thomas, B. Davidson, and S. Taylor-robinson, Cholangiocarcinoma, The Lancet, vol.366, issue.9493, pp.1303-1317, 2005.
DOI : 10.1016/S0140-6736(05)67530-7

Y. Shaib and H. El-serag, The Epidemiology of Cholangiocarcinoma, Seminars in Liver Disease, vol.24, issue.2, pp.115-140, 2004.
DOI : 10.1055/s-2004-828889

H. Shin, J. Oh, E. Masuyer, M. Curado, V. Bouvard et al., Epidemiology of cholangiocarcinoma: An update focusing on risk factors, Cancer Science, vol.49, issue.Suppl 1, pp.579-85, 2010.
DOI : 10.1111/j.1349-7006.2009.01458.x

T. Lee, S. Lee, D. Suh, and S. Jung, Hepatitis B Virus Infection and Intrahepatic Cholangiocarcinoma in Korea: A Case-Control Study, The American Journal of Gastroenterology, vol.120, issue.7, 2008.
DOI : 10.1111/j.1572-0241.2008.01796.x

T. Welzel, L. Mellemkjaer, and K. Mcglynn, Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: A nationwide case-control study, International Journal of Cancer, vol.1, issue.3, pp.638-679, 2007.
DOI : 10.1002/ijc.22283

W. Palmer and T. Patel, Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma, Journal of Hepatology, vol.57, issue.1, pp.69-76, 2012.
DOI : 10.1016/j.jhep.2012.02.022

J. Huai, J. Ding, X. Ye, and Y. Chen, Inflammatory Bowel Disease and Risk of Cholangiocarcinoma: Evidence from a Meta-analysis of Population-based Studies, Asian Pacific Journal of Cancer Prevention, vol.15, issue.8, pp.3477-3482
DOI : 10.7314/APJCP.2014.15.8.3477

A. Patel, D. Harnois, G. Klee, and N. Larusso, The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis, The American Journal of Gastroenterology, vol.4, issue.1, pp.204-207, 2000.
DOI : 10.1111/j.1572-0241.2000.01685.x

D. Tamandl, B. Herberger, B. Gruenberger, H. Puhalla, M. Klinger et al., Influence of Hepatic Resection Margin on Recurrence and Survival in Intrahepatic Cholangiocarcinoma, Annals of Surgical Oncology, vol.15, issue.10, pp.2787-2794
DOI : 10.1245/s10434-008-0081-1

T. Uenishi, O. Yamazaki, and H. Tanaka, Serum Cytokeratin 19 Fragment (CYFRA21-1) as a Prognostic Factor in Intrahepatic Cholangiocarcinoma, Annals of Surgical Oncology, vol.132, issue.1 Suppl, pp.583-589
DOI : 10.1245/s10434-007-9650-y

C. Valls, A. Guma, I. Puig, A. Sanchez, E. Andi et al., Intrahepatic peripheral cholangiocarcinoma: CT evaluation, Abdominal Imaging, vol.25, issue.5, pp.490-496, 2000.
DOI : 10.1007/s002610000079

J. Hamrick-turner, P. Abbitt, and R. Pr, Intrahepatic cholangiocarcinoma: MR appearance., American Journal of Roentgenology, vol.158, issue.1, pp.77-79, 1992.
DOI : 10.2214/ajr.158.1.1309221

A. Karakatsanis, I. Papaconstantinou, M. Gazouli, A. Lyberopoulou, G. Polymeneas et al., Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance, Molecular Carcinogenesis, vol.26, issue.4, pp.297-303
DOI : 10.1002/mc.21864

R. Nishino, M. Honda, T. Yamashita, H. Takatori, H. Minato et al., Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma, Journal of Hepatology, vol.49, issue.2, pp.207-223, 2008.
DOI : 10.1016/j.jhep.2008.03.025

J. Bruix and M. Sherman, Management of hepatocellular carcinoma, Hepatology, vol.35, issue.5, pp.1208-1244, 2005.
DOI : 10.1002/hep.20933

J. Tan, N. Coburn, N. Baxter, A. Kiss, and C. Law, Surgical Management of Intrahepatic Cholangiocarcinoma - A Population-Based Study, Annals of Surgical Oncology, vol.70, issue.2, pp.600-608, 2008.
DOI : 10.1245/s10434-007-9627-x

D. Jong, M. Nathan, H. Sotiropoulos, G. Paul, A. Alexandrescu et al., Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment, Journal of Clinical Oncology, vol.29, issue.23, pp.3140-3145, 2011.
DOI : 10.1200/JCO.2011.35.6519

G. Sotiropoulos, M. Bockhorn, G. Sgourakis, E. Brokalaki, E. Molmenti et al., R0 Liver Resections for Primary Malignant Liver Tumors in the Noncirrhotic Liver: A Diagnosis-Related Analysis, Digestive Diseases and Sciences, vol.205, issue.4, pp.887-94, 2009.
DOI : 10.1007/s10620-008-0408-6

H. Bektas, C. Yeyrek, M. Kleine, F. Vondran, K. Timrott et al., Surgical treatment for intrahepatic cholangiocarcinoma in Europe: a single center experience, Journal of Hepato-Biliary-Pancreatic Sciences, vol.21, issue.3, pp.131-138, 2015.
DOI : 10.1002/jhbp.158

A. Horgan, E. Amir, T. Walter, and J. Knox, Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis, Journal of Clinical Oncology, vol.30, issue.16, pp.1934-1974, 2012.
DOI : 10.1200/JCO.2011.40.5381

T. Takada, H. Amano, H. Yasuda, Y. Nimura, and T. Matsushiro, Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma?: A Phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma, Cancer. 15 oct, vol.95, issue.8, pp.1685-95, 2002.

Y. Chen, Z. Zeng, Z. Tang, and F. J. , Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients, BMC Cancer, vol.26, issue.4, pp.492-501, 2010.
DOI : 10.1200/JCO.2007.14.3529

Z. Zeng, Z. Tang, J. Fan, J. Zhou, L. Qin et al., Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients, Cancer J, vol.12, issue.2, pp.113-135, 2006.

E. Shinohara, N. Mitra, M. Guo, and J. Metz, Radiation Therapy Is Associated With Improved Survival in the Adjuvant and Definitive Treatment of Intrahepatic Cholangiocarcinoma, International Journal of Radiation Oncology*Biology*Physics, vol.72, issue.5, pp.1495-501, 2008.
DOI : 10.1016/j.ijrobp.2008.03.018

W. Jiang, Z. Zeng, Z. Tang, J. Fan, J. Zhou et al., Benefit of radiotherapy for 90 patients with resected intrahepatic cholangiocarcinoma and concurrent lymph node metastases, Journal of Cancer Research and Clinical Oncology, vol.135, issue.9, pp.1323-1354, 2010.
DOI : 10.1007/s00432-010-0783-1

R. Seidensticker, J. Ricke, and M. Seidensticker, Integration of chemoembolization and radioembolization into multimodal treatment of cholangiocarcinoma, Best Practice & Research Clinical Gastroenterology, vol.29, issue.2, pp.319-351, 2015.
DOI : 10.1016/j.bpg.2015.02.009

D. P. Al-adra, R. S. Gill, and S. Liau, Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: A systematic review and pooled analysis, European Journal of Surgical Oncology (EJSO), vol.41, issue.1, pp.120-127
DOI : 10.1016/j.ejso.2014.09.007

M. Aljiffry, A. Abdulelah, M. Walsh, K. Peltekian, I. Alwayn et al., Evidence-Based Approach to Cholangiocarcinoma: A Systematic Review of the Current Literature, Journal of the American College of Surgeons, vol.208, issue.1, pp.134-181, 2009.
DOI : 10.1016/j.jamcollsurg.2008.09.007

B. Glimelius, K. Hoffman, P. Sjoden, and G. Jacobsson, Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer, Annals of Oncology, vol.7, issue.6, pp.593-600, 1996.
DOI : 10.1093/oxfordjournals.annonc.a010676

J. Valle, H. Wasan, P. Johnson, E. Jones, L. Dixon et al., Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study ??? The UK ABC-01 Study, British Journal of Cancer, vol.18, issue.4, pp.621-628, 2009.
DOI : 10.1002/1097-0142(19841015)54:8<1513::AID-CNCR2820540806>3.0.CO;2-9

J. Valle, H. Wasan, D. Palmer, D. Cunningham, A. Anthoney et al., Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer, New England Journal of Medicine, vol.362, issue.14, pp.1273-81, 2010.
DOI : 10.1056/NEJMoa0908721

T. Okusaka, K. Nakachi, A. Fukutomi, N. Mizuno, S. Ohkawa et al., Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan, British Journal of Cancer, vol.69, issue.4, pp.469-74, 2010.
DOI : 10.1038/sj.bjc.6605377

N. Schweitzer and A. Vogel, Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies, Best Practice & Research Clinical Gastroenterology, vol.29, issue.2, pp.345-53, 2015.
DOI : 10.1016/j.bpg.2015.01.002

A. Sharma, B. Mohanti, R. V. Shukla, N. Pal, S. Dwary et al., A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer, Cancer Chemotherapy and Pharmacology, vol.99, issue.6, pp.497-502, 2010.
DOI : 10.1007/s00280-009-1055-0

T. Walter, A. Horgan, M. Mcnamara, L. Mckeever, T. Min et al., Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: A large retrospective study, European Journal of Cancer, vol.49, issue.2, pp.329-364, 2013.
DOI : 10.1016/j.ejca.2012.08.003

A. Lamarca, R. Hubner, D. Ryder, W. Valle, and J. , Second-line chemotherapy in advanced biliary cancer: a systematic review, Annals of Oncology, vol.25, issue.12, pp.2328-2366, 2014.
DOI : 10.1093/annonc/mdu162

K. Lafaro, D. Cosgrove, J. Geschwind, I. Kamel, J. Herman et al., Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management, Gastroenterology Research and Practice, vol.143, issue.12, pp.1-14, 2015.
DOI : 10.1111/ajt.12591

G. Sapisochin, N. Fidelman, J. Roberts, and F. Yao, Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma, Liver Transplantation, vol.16, issue.8, pp.934-976, 2011.
DOI : 10.1002/lt.22307

P. Tabrizian, G. Jibara, J. Hechtman, B. Franssen, D. Labow et al., Outcomes following resection of intrahepatic cholangiocarcinoma, HPB, vol.17, issue.4, pp.344-351, 2015.
DOI : 10.1111/hpb.12359

K. Paik, J. Jung, J. Heo, and S. Choi, What prognostic factors are important for resected intrahepatic cholangiocarcinoma?, Journal of Gastroenterology and Hepatology, vol.241, issue.5, pp.766-770, 2008.
DOI : 10.1007/s00535-006-1877-z

S. Choi, K. Kim, J. Choi, S. Park, J. Choi et al., The Prognosis and Survival Outcome of Intrahepatic Cholangiocarcinoma Following Surgical Resection: Association of Lymph Node Metastasis and Lymph Node Dissection with Survival, Annals of Surgical Oncology, vol.10, issue.11, 2009.
DOI : 10.1245/s10434-009-0631-1

S. Liu, Q. Zheng, and Z. Song, Serum carbohydrate antigen (CA) 19-9 as a prognostic factor in cholangiocarcinoma: A meta-analysis, Frontiers of Medicine in China, vol.100, issue.9, pp.457-62, 2010.
DOI : 10.1007/s11684-010-0240-1

O. Hyder, H. Marques, C. Pulitano, J. Marsh, S. Alexandrescu et al., A Nomogram to Predict Long-term Survival After Resection for Intrahepatic Cholangiocarcinoma, JAMA Surgery, vol.149, issue.5, pp.432-438, 2014.
DOI : 10.1001/jamasurg.2013.5168

D. Mcmillan, The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer, Cancer Treatment Reviews, vol.39, issue.5, pp.534-540, 2013.
DOI : 10.1016/j.ctrv.2012.08.003

M. Proctor, D. Morrison, D. Talwar, and S. Balmer, An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study, British Journal of Cancer, vol.3, issue.4, pp.726-734, 2011.
DOI : 10.1161/CIRCULATIONAHA.109.851873

Y. Oshiro, R. Sasaki, K. Fukunaga, and T. Kondo, Inflammation-based prognostic score is a useful predictor of postoperative outcome in patients with extrahepatic cholangiocarcinoma, Journal of Hepato-Biliary-Pancreatic Sciences, vol.75, issue.8, pp.389-395, 2013.
DOI : 10.1007/s00534-012-0550-6

T. Moriwaki, K. Ishige, M. Araki, S. Yoshida, M. Nishi et al., Glasgow Prognostic Score predicts poor prognosis among advanced biliary tract cancer patients with good performance status, Medical Oncology, vol.35, issue.2, p.287, 2014.
DOI : 10.1007/s12032-014-0287-y

A. Iwaku, A. Kinoshita, H. Onoda, N. Fushiya, H. Nishino et al., The Glasgow Prognostic Score accurately predicts survival in patients with biliary tract cancer not indicated for surgical resection, Medical Oncology, vol.246, issue.1, p.787, 2014.
DOI : 10.1007/s12032-013-0787-1

M. Okuno, T. Ebata, Y. Yokoyama, T. Igami, and G. Sugawara, Evaluation of inflammationbased prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma, J Gastroenterol, 2015.

M. Shibutani and K. Hirawaka, Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer, Anticancer Res, 2015.

B. Ghanim, T. Schweiger, J. Jedamzik, O. Glueck, and K. Hoetzenecker, Elevated inflammatory parameters and inflammation scores are associated with poor prognosis in patients undergoing pulmonary metastasectomy for colorectal cancer, Interactive CardioVascular and Thoracic Surgery, vol.21, issue.5, p.206, 2015.
DOI : 10.1093/icvts/ivv206

S. Morinaga, M. Murakawa, Y. Katayama, K. Yamaoku, T. Aoyama et al., Glasgow Prognostic Score Predicts Clinical Outcomes in Patients with Pancreatic Cancer Undergoing Adjuvant Gemcitabine Monotherapy After Curative Surgery, Anticancer Res, vol.35, issue.9, pp.4865-70, 2015.

Y. Okamura, R. Ashida, T. Ito, T. Sugiura, K. Mori et al., Preoperative Neutrophil to Lymphocyte Ratio and Prognostic Nutritional Index Predict Overall Survival After Hepatectomy for Hepatocellular Carcinoma, World Journal of Surgery, vol.23, issue.6, pp.1501-1510
DOI : 10.1007/s00268-015-2982-z

S. Khan, M. Toledano, and S. Taylor-robinson, Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma, HPB, vol.10, issue.2, pp.77-82, 2008.
DOI : 10.1080/13651820801992641

S. Oh, C. Jeong, S. Hong, T. Kim, and J. Kang, Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness, Investigational New Drugs, vol.24, issue.5, pp.1066-1072, 2011.
DOI : 10.1007/s10637-010-9417-3